Concomitant monitoring ofWT1andFLT3-ITDexpression inFLT3-ITDacute myeloid leukemia patients: which should we trust as a minimal residual disease marker?
Federico De Marchi; Anna Candoni; Maria Elena Zannier; Lisa Haley; Bonnie Wing Yin Lau; Renato Fanin
Author Information: Division of Hematology and BMT, Department of Experimental and Clinical Medical Sciences, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.